Position:
Clinical Assistant Professor
Division:
Nephrology
Research Interests:

Polycystic kidney disease, home dialysis, health program evaluation, health program implementation

Research Summary:

Dr. Micheli (Mike) Bevilacqua is a nephrologist with additional training in health administration and divideds his time between clinical medicine and nephrology administration. His clinical nephrology practice is based in Fraser Health Authority, and he is involved in several administrative roles with the BC Provincial Renal Agency. He is the chair of the Kidney Care Committee which oversees the care of over 15,000 British Columbians living with chronic kidney disease and he is also the Medical Lead for the BC Polycystic Kidney Disease Network which aims to optimize management of PKD in BC. Dr. Bevilacqua’s research  interests include polycystic kidney disease and home dialysis specifically and more generally knowledge translation, systems improvement and evaluating care delivery.

Education:
Simon Fraser University, BSc
University of Calgary, MD
University of British Columbia, MHA
Affiliations
BC Provincial Renal Agency, Kidney Care Committee, Chair
Recent Publications:

Bevilacqua MU, Hague CJ, Romann A, Sheitt H, Vasilescu DM, Yi TW, et al. CT of Kidney Volume in Autosomal Dominant Polycystic Kidney Disease: Accuracy, Reproducibility, and Radiation Dose. Radiology. 2019 Apr 9;181830.

Bevilacqua MU, Er L, Copland MA, Singh RS, Jamal A, Dunne O, et al. PREVALENCE-BASED TARGETS UNDERESTIMATE HOME DIALYSIS PROGRAM ACTIVITY AND REQUIREMENTS FOR GROWTH. Peritoneal Dialysis International. 2018 Feb 7;pdi.2017.00171.

Soroka S, Alam A, Bevilacqua M, Girard L-P, Komenda P, Loertscher R, et al. Updated Canadian Expert Consensus on Assessing Risk of Disease Progression and Pharmacological Management of Autosomal Dominant Polycystic Kidney Disease. Canadian Journal of Kidney Health and Disease. 2018 Jan;5:205435811880158.

Bevilacqua MU, Chiu HHL, Saunders S, Turnbull L, Taylor PA, Singh RS, et al. The value of patient and provider reported experiences in evaluating home-based assisted peritoneal dialysis. European Journal for Person Centered Healthcare. 2017 Sep 26;5(3):404.

Bevilacqua MU, Turnbull L, Saunders S, Er L, Chiu H, Hill P, et al. Evaluation of a 12-Month Pilot of Long-Term and Temporary Assisted Peritoneal Dialysis. Peritoneal Dialysis International. 2017 May;37(3):307–13.

Soroka S, Alam A, Bevilacqua M, Girard L-P, Komenda P, Loertscher R, et al. Assessing Risk of Disease Progression and Pharmacological Management of Autosomal Dominant Polycystic Kidney Disease: A Canadian Expert Consensus. Canadian Journal of Kidney Health and Disease. 2017 Jan;4:205435811769578.

Awards & Recognition:
  • Kidney Foundation of Canada BC Yukon Branch: 2018 Public Awareness Award
  • UBC SPPH: 2017 Robert Wood Johnson Award
  • UBC Department of Medicine: 2015 Richard E Beck Prize

MED 421

MED 411

INDE 420

PHAR 409